Optimizing outcomes in men with prostate cancer: the cardiovascular event lowering (CaELo) pathways.
Risk of cardiovascular disease is higher among men with prostate cancer than men without, and prostate cancer treatments (especially those that are hormonally based) are associated with increased cardiovascular risk. An 11-member panel of urologic, medical …